CUAMC
WVE icon

China Universal Asset Management Company’s Wave Life Sciences WVE Stock Holding History

China Universal Asset Management Company’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Sell
33,407
-6,335
-16% -$82.5K 0.02% 335
2025
Q4 		$676K Sell
39,742
-38,153
-49% -$388K 0.05% 227
2025
Q3 		$570K Sell
77,895
-15,475
-17% -$125K 0.05% 232
2025
Q2 		$607K Buy
93,370
+40,850
+78% +$270K 0.06% 228
2025
Q1 		$424K Sell
52,520
-1,747
-3% -$19.1K 0.04% 258
2024
Q4 		$671K Buy
54,267
+30,276
+126% +$404K 0.06% 212
2024
Q3 		$197K Buy
23,991
+9,603
+67% +$57.4K 0.02% 301
2024
Q2 		$71.8K Sell
14,388
-9,085
-39% -$51.8K 0.01% 324
2024
Q1 		$145K Buy
23,473
+12,017
+105% +$60.2K 0.02% 329
2023
Q4 		$57.9K Buy
11,456
+8,920
+352% +$47.7K 0.01% 356
2023
Q3 		$14.6K Buy
2,536
+1,247
+97% +$5.69K ﹤0.01% 320
2023
Q2 		$4.69K Sell
1,289
-36
-3% -$145 ﹤0.01% 378
2023
Q1 		$5.74K Buy
1,325
+442
+50% +$2.02K ﹤0.01% 350
2022
Q4 		$6.18K Buy
883
+70
+9% +$323 ﹤0.01% 273
2022
Q3 		$3K Buy
+813
New +$2.69K ﹤0.01% 338

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

China Universal Asset Management Company's WVE Position: Q1 2026 in Review

China Universal Asset Management Company reduced its Wave Life Sciences (WVE) stake by 16% in Q1 2026, selling an estimated $82.5K and leaving 33,407 shares worth $242K. The position accounts for 0.02% of the portfolio, ranked #335.

China Universal Asset Management Company first reported a position in WVE in Q3 2022 and has held it in 15 quarters since. The position peaked at $676K in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • China Universal Asset Management Company held 33,407 shares of Wave Life Sciences worth $242K as of Q1 2026.
  • China Universal Asset Management Company sold 6,335 Wave Life Sciences shares in Q1 2026, an estimated $82.5K.
  • Wave Life Sciences made up 0.02% of China Universal Asset Management Company's portfolio in Q1 2026, its #335 holding.
  • China Universal Asset Management Company first reported a position in Wave Life Sciences in Q3 2022 and has held it in 15 quarters since.
  • China Universal Asset Management Company's Wave Life Sciences position peaked at $676K in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.